Endometriosis Trial, Recruiting (NCT07553676)

Endometriosis Trial, Recruiting NCT07553676 Sponsor: Diamens FlexCo Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT07553676 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women between the ages of 14 and 49
Women who are currently having periods
Women who have been diagnosed with endometriosis confirmed by a tissue sample (biopsy) or by a medical scan/imaging
Women who have had a keyhole surgery (laparoscopy) that showed no signs of endometriosis
Healthy women with no symptoms of endometriosis and whose medical scans show no signs of the condition

Who may not be able to join:

Women who have stopped having periods (for any reason)
Women who are pregnant
Women who have or have had cancer or another oncological (tumour-related) disease
Women who are currently using certain hormone-based medications called GnRH agonists or antagonists (confirm with trial site if you are unsure whether your medication falls into this category)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4367764346422

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07553676

Sponsor: Diamens FlexCo

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: +4367764346422

More information: https://clinicaltrials.gov/study/NCT07553676

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women between the ages of 14 and 49
Women who are currently having periods
Women who have been diagnosed with endometriosis confirmed by a tissue sample (biopsy) or by a medical scan/imaging
Women who have had a keyhole surgery (laparoscopy) that showed no signs of endometriosis
Healthy women with no symptoms of endometriosis and whose medical scans show no signs of the condition

Who may not be able to join:

Women who have stopped having periods (for any reason)
Women who are pregnant
Women who have or have had cancer or another oncological (tumour-related) disease
Women who are currently using certain hormone-based medications called GnRH agonists or antagonists (confirm with trial site if you are unsure whether your medication falls into this category)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Diamens FlexCo

Registry

ClinicalTrials.gov

Start date

6 May 2026

Est. completion

1 December 2029

Where this trial is recruiting

🇦🇹 Austria 🇩🇪 Germany

Primary endpoints

Diagnostic Accuracy of the Menstrual Blood-Based Biomarker Test for Endometriosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov